Events  Deals  Jobs  SF Climate Week 2024 
    Sign in  
 
 
With Timo Minssen (Dir. Centre For Advanced Studies In Biomedical Innovation Law CeBIL @ University of Copenhagen).
Tue, Jun 18, 2019 @ 04:00 PM   FREE   NY Genome Center, 101 6th Ave
 
   
 
 
              

    
 
Sign up for our awesome New York
Tech Events weekly email newsletter.
   
LOCATION
EVENT DETAILS
4-5PM: Lecture & Audience Q&A5-6PM:Networking & Cocktail Reception
Timo MinssenProfessor, Jur.Dr., LL.M., M.I.C.L.Director, Centre for Advanced Studies in Biomedical Innovation Law (CeBIL)University of Copenhagen


Timo Minssen is Professor of Law at the University of Copenhagen (UCPH) & the Founding Director of UCPH's Center for Advanced Studies in Biomedical Innovation Law (CeBIL). He specializes in the interface of Intellectual Property, Competition & Regulatory Law with a special focus on new technologies in the health & life sciences, such as AI & big data-driven precision medicine. His studies involve a plethora of legal issues emerging in the lifecycle of biotechnological & medical products & processes - from the regulation of research & incentives for innovation to technology transfer & commercialization.
At UCPH he had led several large interdisciplinary research projects in synthetic biology, precision medicine & research infrastructures. At present, he is the principal investigator & grant holder of a large research program in biomedical innovation law, funded by the Novo Nordisk Foundation. Anchored in Copenhagen, it involves close collaboration with international core partners, such as Harvard Law School, Harvard Medical School, as well as the Universities of Cambridge & Michigan. Timo has also been the legal expert advisory board member of EU Commission studies of the pharmaceutical sector. He is the steering committee member of the Danish Association for the Protection of Industrial Property & scientific advisory board member of the Copenhagen Centre for Regulatory Sciences (CORS), where he works inter alia with the protection & regulation of biologics & biosimilars.
Timo holds a German law degree from the University of Gttingen, as well as biotech & IP -related LL.M. M.I.C.L., LL.Lic. & LL.D. degrees from Lund & Uppsala University. He has been Visiting Research Fellow at the Universities of Cambridge & Oxford, Harvard Law School, Chicago-Kent College of Law, & at the Max Planck Institute for Innovation & Competition. Moreover, he was trained in the German Court system & at the European Patent Office.

Q&A Moderator:
Jacob S. SherkowProfessor of LawInnovation Center for Law & TechnologyNew York Law School
Adjunct Assistant Professor of Health Policy & ManagementColumbia University Mailman School of Public Health
Permanent Visiting ProfessorCentre for Advanced Studies in Biomedical Innovation Law (CeBIL)University of Copenhagen, Faculty of Law

 
 
 
 
© 2024 GarysGuide      About    Feedback    Press    Terms